CardiGraphormer: Unveiling the Power of Self-Supervised Learning in Revolutionizing Drug Discovery
원문 초록
In the expansive realm of drug discovery, with approximately 15,000 known drugs and only around 4,200 approved, the combinatorial nature of the chemical space presents a formidable challenge. While Artificial Intelligence (AI) has emerged as a powerful ally, traditional AI frameworks face significant hurdles. This manuscript introduces CardiGraphormer, a groundbreaking approach that synergizes self-supervised learning (SSL), Graph Neural Networks (GNNs), and Cardinality Preserving Attention to revolutionize drug discovery. CardiGraphormer, a novel combination of Graphormer and Cardinality Preserving Attention, leverages SSL to learn potent molecular representations and employs GNNs to extract molecular fingerprints, enhancing predictive performance and interpretability while reducing computation time. It excels in handling complex data like molecular structures and performs tasks associated with nodes, pairs of nodes, subgraphs, or entire graph structures. CardiGraphormer's potential applications in drug discovery and drug interactions are vast, from identifying new drug targets to predicting drug-to-drug interactions and enabling novel drug discovery. This innovative approach provides an AI-enhanced methodology in drug development, utilizing SSL combined with GNNs to overcome existing limitations and pave the way for a richer exploration of the vast combinatorial chemical space in drug discovery.
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
Exploring Non-contrastive Self-supervised Representation Learning for Image-based Profiling
Graph Neural Networks in Modern AI-aided Drug Discovery
B-XAIC Dataset: Benchmarking Explainable AI for Graph Neural Networks Using Chemical Data
Assay2Mol: large language model-based drug design using BioAssay context
RetFiner: A Vision-Language Refinement Scheme for Retinal Foundation Models
Boosting Generative Adversarial Transferability with Self-supervised Vision Transformer Features
토론
이 논문과 연결된 포럼 글이 아직 없습니다.